ovarian               package:lbdatasets               R Documentation

_D_a_t_a _f_r_o_m _a _R_C_T _o_n _a_d_v_a_n_c_e_d _o_v_a_r_i_a_n _c_a_n_c_e_r

_D_e_s_c_r_i_p_t_i_o_n:

     Controlled clinical trial on N = 476 women with advanced ovarian
     cancer. The objective is to compare three treatment regimens:
     monochemotherapy P (cisplatin), polichemotherapies
     cyclophosphamide (CP) and cyclophosphamide + adriamycin (CAP).

_U_s_a_g_e:

     ovarian
     
_F_o_r_m_a_t:

     A data frame with 476 observations on the following variables.

     ‘npaz’ patient id

     ‘tures’ residual tumor size (1 = absent, 2 = micro, 3 = <= 1cm, 4
          = 1-2cm, 5 = 2-5cm, 6 = 5-10cm, 7 = > 10 cm

     ‘tures_cl’ residual tumor size classes

     ‘kar’ Karnofsky Index

     ‘kar_cl’ Karnofsky Index classes

     ‘histo’ Histology

     ‘histo_cl’ Histology classes

     ‘figo’ Federation Internationale de Gynecologie et d'Obstetrique
          with stages I, II, III

     ‘treatment’ treatment group (1 = CAP, 2 = CP, 3 = P)

     ‘surv’ event indicator (0 = censored, 1 = death)

     ‘survtime’ time to event (days)

     ‘status’ ??

_D_e_t_a_i_l_s:

     Endpoint is the overall survival. The prognostic factors available
     are residual tumor size, Karnofsky Index, Histology and the
     Federation Internationale de Gynecologie et d'Obstetrique
     classification.

_E_x_a_m_p_l_e_s:

     head(ovarian)
     


